01 1Hangzhou Sinodo Pharm Technology Co.,Ltd
01 1Macimorelin
01 1Blank
NDC Package Code : 82907-990
Start Marketing Date : 2024-08-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
80
PharmaCompass offers a list of Macimorelin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Macimorelin manufacturer or Macimorelin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Macimorelin manufacturer or Macimorelin supplier.
PharmaCompass also assists you with knowing the Macimorelin API Price utilized in the formulation of products. Macimorelin API Price is not always fixed or binding as the Macimorelin Price is obtained through a variety of data sources. The Macimorelin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Macimorelin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Macimorelin, including repackagers and relabelers. The FDA regulates Macimorelin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Macimorelin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Macimorelin supplier is an individual or a company that provides Macimorelin active pharmaceutical ingredient (API) or Macimorelin finished formulations upon request. The Macimorelin suppliers may include Macimorelin API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Macimorelin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Macimorelin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Macimorelin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Macimorelin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Macimorelin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Macimorelin suppliers with NDC on PharmaCompass.
